117 related articles for article (PubMed ID: 4791964)
1. [Experimental study of subcutaneous and aerosol vaccination against the plaque in cynocephalous monkeys. Absence of correlation between hemagglutination and precipitant antibodies and protection].
Fournier J; Paul G; Chomel J; Dodin A; Fontanges R
Ann Microbiol (Paris); 1973 Oct; 124(3):315-28. PubMed ID: 4791964
[No Abstract] [Full Text] [Related]
2. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
Eyles JE; Butcher WA; Titball RW; Hill J
Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
[TBL] [Abstract][Full Text] [Related]
3. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis.
Meyer KF; Hightower JA; McCrumb FR
J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248
[No Abstract] [Full Text] [Related]
4. Measuring the efficacy of vaccination in affording protection against plague.
Williams JE; Cavanaugh DC
Bull World Health Organ; 1979; 57(2):309-13. PubMed ID: 312163
[TBL] [Abstract][Full Text] [Related]
5. [The plague: disease and vaccine?].
Michel P; Rasoamanana B; Rasolofonirina N; Roux J
Dakar Med; 1992; 37(2):183-9. PubMed ID: 1345094
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the reliability and sensitivity of three serological procedures in detecting antibody to Yersinia pestis (Pasteurella pestis).
Marshall JD; Mangiafico JA; Cavanaugh DC
Appl Microbiol; 1972 Aug; 24(2):202-4. PubMed ID: 5071650
[TBL] [Abstract][Full Text] [Related]
7. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
Leary SE; Eley SM; Williamson ED; Titball RW
Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
[No Abstract] [Full Text] [Related]
8. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague].
Zakrevskiĭ VI; Plekhanova NG
Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277
[TBL] [Abstract][Full Text] [Related]
9. [Duration and intensity of postvaccinal immunity to plague in experimental animals].
Chicherin IuV; Evstigneev VI; Lebedinskiĭ VA
Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):95-8. PubMed ID: 409008
[TBL] [Abstract][Full Text] [Related]
10. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
Reed DS; Martinez MJ
Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
[TBL] [Abstract][Full Text] [Related]
11. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of revaccinating hamadryas baboons with NISS live dried plague vaccine and fraction I of the plague microbe].
Byvalov AA; Pautov VN; Chicherin IuV; Lebedinskiĭ VA; Evtigneev VI
Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr; (4):74-6. PubMed ID: 6741359
[TBL] [Abstract][Full Text] [Related]
13. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
[TBL] [Abstract][Full Text] [Related]
14. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
Elvin SJ; Williamson ED
Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
[TBL] [Abstract][Full Text] [Related]
15. Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffkine and freeze-dried plague vaccine.
Meyer KF; Smith G; Foster LE; Marshall JD; Cavanaugh DC
J Infect Dis; 1974 May; 129():Suppl:S30-6. PubMed ID: 4825247
[No Abstract] [Full Text] [Related]
16. A plant-produced plague vaccine candidate confers protection to monkeys.
Mett V; Lyons J; Musiychuk K; Chichester JA; Brasil T; Couch R; Sherwood R; Palmer GA; Streatfield SJ; Yusibov V
Vaccine; 2007 Apr; 25(16):3014-7. PubMed ID: 17287055
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
[TBL] [Abstract][Full Text] [Related]
18. Large-scale purification of the F1 antigen of Yersinia pestis.
Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
[No Abstract] [Full Text] [Related]
19. Pathogenicity and immunogenic efficacy of a live attentuated plaque vaccine in vervet monkeys.
Hallett AF; Isaäcson M; Meyer KF
Infect Immun; 1973 Dec; 8(6):876-81. PubMed ID: 4206343
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
Jones T; Adamovicz JJ; Cyr SL; Bolt CR; Bellerose N; Pitt LM; Lowell GH; Burt DS
Vaccine; 2006 Mar; 24(10):1625-32. PubMed ID: 16243411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
